TTRX
Turn Therapeutics Inc.
There isn't enough reported data to score TTRX yet.
TTRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
TTRX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
TTRX PE Valuation
TTRX has no meaningful PE right now: it lost money over the past year.
TTRX Forward outlook
There aren't enough analyst estimates for TTRX to show an outlook.
TTRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.43 | -$0.25 |
| Q2 2026 | -$0.29 | -$0.15 |
| Q1 2026 | -$0.18 | -$0.10 |
TTRX lost $0.43 per share over the past year, and its loss has widened in each of the last three quarters.
TTRX Quarterly Revenue
TTRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$923.4K | -$423.4K |
| Q1 2026 | -$1.6M | -$1.3M |
| Q4 2025 | -$1.2M | -$745.7K |
TTRX has burned cash in almost every quarter: −$5M over the past year, against −$2M the year before.
TTRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +349K shares |
| 1 year | +7.7% | +2.2M shares |
TTRX has 30M diluted shares, up 7.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
TTRX Net Leverage
TTRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TTRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 24.7 | Neutral |
TTRX's weekly RSI is 52 (neutral) and its Stochastic is 25 (neutral).
TTRX PE vs Healthcare Sector
TTRX has no meaningful PE right now: it lost money over the past year.
TTRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.1 | 8.7% below |
| 20 week MA | $10.4 | 2.6% below |
| 50 week MA | $6.65 | 52% above |
TTRX has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 52% above its 50-week average.
TTRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $7.45 | $2.74 | -63% |
| 2026 YTD | $2.74 | $10.1 | +270% |
TTRX has finished every year since 2025 lower, and it's up 270% so far in 2026.